Nova Hub
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”)
NOVA MSC BERHAD 14 May 2024 Type Announcement Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING Description NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) PROPOSED PLACEMENT OF NEW ORDINARY SHARES IN NOVAMSC (“SHARES” OR “NOVAMSC SHARES”) (“PLACEMENT SHARES”) OF UP TO 10% OF NOVAMSC’S ISSUED SHARES (“PLACEMENT”) Reference made to the Company’s announcement dated…
OTHERS Nova MSC Berhad (NOVAMSC or Company) Term Sheets With Mark Investment Group VCC
NOVA MSC BERHAD 10 May 2024 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) Term Sheets With Mark Investment Group VCC 1. Introduction The Board of Directors of NOVAMSC wishes to announce the execution of the following separate Term Sheets by its subsidiary companies on 10 May 2024: (i) Term Sheet between Dex-Lab Pte. Ltd….
VESALIUS GOES LIVE IN KASIH IBU SABA, BALI
10 May 2024 – On the recent Sunday, VESALIUS – Nova’s hospital information system complete with Electronic Medical Record (EMR) went LIVE in Kasih Ibu Hospital, Saba in Bali. KIH Saba is the 3rd hospital in the group to hop onto the VESALIUS system. From the word get-go in early March, the things moved at breakneck speed. There was hardware…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 08 May 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 155,200 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : INTENTION TO DEAL DURING CLOSED PERIOD
NOVA MSC BERHAD 07 May 2024 Subject Intention to Deal During Closed Period No Salutation Name Designation Description Of “Others” Designation 1 MR LOH GUAN HUAT SUNNY Others Executive Chairman Nature of Interest Direct Interest Description of Securities Ordinary shares No of Securities Held 0 % of Securities Held 0.000 2 MR LOH GUAN HUAT SUNNY Others Executive…
WILLIAM & MARY | RAYMOND A. MASON SCHOOL OF BUSINESS EMBA COHORT VISITS EYRIS
7 May 2024 – EyRIS had a great day hosting an EMBA delegation from William & Mary | Raymond A. Mason School of Business, a distinguished public research university and the 2nd oldest institution of higher learning located in Williamsburg, Virginia. WM’s Executive MBA is designed for focused, driven leaders who are positioned to move into senior executive and C-suite…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 03 May 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 422,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
SELENA+ ADOPTED AS FIRST MEDICAL AI IN BRUNEI DARUSSALAM
24 Apr 2024 – It is estimated that Brunei Darussalam has a diabetes prevalence of about 13% and evidence reveals that 1 in 3 diabetic patients develops diabetic retinopathy, which left untreated can lead to blindness. This morning, Jerudong Park Medical Centre (JPMC) launched the SELENA+ Artificial Intelligence Diabetic Retinopathy Screening Service – the first AI eye screening service in…
SELENA+ IN ACTION DURING DIABETES MALAYSIA AGM
21 Apr 2024 – Nova MSC provided eye screening for the members of Diabetes Malaysia (Penang Branch) during their Annual General Meeting (AGM) in Penang Adventist Hospital (PAH). With the help from Diabetes Malaysia, we have managed to screen more than 20 of their members for eye diseases using SELENA+ an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma…
OTHERS Nova MSC Berhad (NOVAMSC or Company) Term Sheets With Jostar Investment VCC
NOVA MSC BERHAD 19 April 2024 Type Announcement Subject OTHERS Description Nova MSC Berhad (NOVAMSC or Company) Term Sheets With Jostar Investment VCC 1. Introduction The Board of Directors of NOVAMSC wishes to announce the execution of the following Term Sheets by its subsidiary companies on 19 April 2024: (i) Term Sheet between Dex-Lab Pte. Ltd. (“Dex-Lab”), a 60%…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 17 April 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 610,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
EYRIS PARTICIPATES IN DIABETIC RETINOPATHY SCREENING INITIATIVE IN MONGOLIA
15 Apr 2024 – EyRIS is thrilled to announce our partnership with iCare in support of Sight For All’s mission to combat preventable blindness in Mongolia. We are humbled to be invited to participate in this meaningful community outreach project by way of contributing our flagship product SELENA+, an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma and Aged-Related…